ZIMBABWE’S drug procurement unit, the National Pharmaceutical Company (NatPharm), says it is now prioritising local medicine manufacturing companies to avoid unnecessary imports. This comes as Billy Rigava, NatPharm’s board chairman, recently said a partnership with local tertiary institutions in the production of Covid-19 tools and equipment had saved the country more than US$4 million in…
Subscribe to read full article. Subscribe today